Reduction of Stent Thrombosis in Patients With Acute Coronary Syndrome Treated With Rivaroxaban in ATLAS ACS 2–TIMI 51

Study Questions:

What is the impact of inhibition of thrombin generation via factor Xa inhibition with rivaroxaban on the risk of stent thrombosis?